Eisai Pulls Weight Loss Drug Lorcaserin from US Market After Request from FDA
The FDA has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. The drug manufacturer, […]